LAURA FRIES: Open Payments
NPI 1154781730 · CANTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$443 in 22 payments from 14 companies in 2025. Trend: 2023 $577 · 2024 $508 · 2025 $443
Food & beverage: $401Education: $43
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $104 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| Mannkind Corporation | 1 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Abbott Laboratories | 2 | $33 |
| Insulet Corporation | 1 | $25 |
| Tandem Diabetes Care, Inc. | 2 | $24 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| Sequel Med Tech, LLC | 1 | $22 |
| Ascendis Pharma Endocrinology Inc | 1 | $20 |
Products named: Ozempic, LEQVIO, AFREZZA, Kerendia, FREESTYLE LIBRE 3, Omnipod, t:slim X2 Insulin Pump with Control-IQ, CRENESSITY.
Industry payments across OH — which companies pay providers there.
